2023
DOI: 10.3389/fcimb.2023.1170505
|View full text |Cite
|
Sign up to set email alerts
|

Stability of SARS-CoV-2 in cold-chain transportation environments and the efficacy of disinfection measures

Abstract: BackgroundLow temperature is conducive to the survival of COVID-19. Some studies suggest that cold-chain environment may prolong the survival of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and increase the risk of transmission. However, the effect of cold-chain environmental factors and packaging materials on SARS-CoV-2 stability remains unclear.MethodsThis study aimed to reveal cold-chain environmental factors that preserve the stability of SARS-CoV-2 and further explore effective disinfectio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…In cells expressing the recombinant S protein we employed two established commercial antibodies with which to compare with the PD5 and sc23 antibodies, these recognise the Nterminal domain (anti-NTD) and the RBD (anti-RBD) in the S1 protein subunit. The anti-NTD and anti-RBD antibodies have been previously used by others to examine and confirm S protein expression using different experimental systems [20][21][22]. The anti-NTD and anti-RBD antibodies were produced by using synthetic peptides from sequences in the region of the S protein at Proline25 (in the S1 subunit N-terminal domain) and Serine459 (in and the RBD).…”
Section: The Pd5 Antibody Recognises a Specific Conformational Change...mentioning
confidence: 99%
“…In cells expressing the recombinant S protein we employed two established commercial antibodies with which to compare with the PD5 and sc23 antibodies, these recognise the Nterminal domain (anti-NTD) and the RBD (anti-RBD) in the S1 protein subunit. The anti-NTD and anti-RBD antibodies have been previously used by others to examine and confirm S protein expression using different experimental systems [20][21][22]. The anti-NTD and anti-RBD antibodies were produced by using synthetic peptides from sequences in the region of the S protein at Proline25 (in the S1 subunit N-terminal domain) and Serine459 (in and the RBD).…”
Section: The Pd5 Antibody Recognises a Specific Conformational Change...mentioning
confidence: 99%